Tamara Elias, M.D., Joins BehaVR, Inc. Board of Directors

This Week’s News in Review

This Week's News in Review! Medical Device News Magazine keeps our readers up-to-date on breaking industry news! Learn how Medical Device News Magazine can help...

New Research Shows Nearly Half of Elderly Suffer Decreased Mobility During Lockdown

In a survey of UK adults with parents over the age of 75, while over half (52%) of respondents remain worried about their parents catching Covid, 48 percent are concerned about parental loneliness, and 46 percent about their parents falling alone and not being able to get up or get help. This figure remained high even among those whose parents are in care homes, with 37% of respondents still most concerned about parents falling over.

American College of Cardiology Names Ravee Kurian COO/CFO

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

February 9, 2021

Tamara Elias, M.D. has been appointed to the company’s board of directors as Independent Director.

Tamara Elias, M.D. currently serves as Vice President and Head of Global Partnerships & Innovation at Merck & Co., Inc.

Her expertise and experience will help guide BehaVR as it expands within behavioral health and works closely with health systems, payer organizations and biopharmaceutical leaders interested in this space.

“We are thrilled to have Dr. Elias join our team as our Independent Director. Her experience with clinical product development and commercialization and deep understanding of both the payer and life sciences sectors will be a huge asset to BehaVR as we continue to grow,” said Aaron Gani founder and CEO of BehaVR. “She has her finger on the pulse of the latest innovations and advancements in healthcare delivery, and we are excited for the perspective she will bring to our company as we expand our collaborations and develop new digital wellness and therapeutic solutions.”

“I am excited about the acceleration of digital wellness solutions to improve healthcare delivery, so look forward to working with the talented BehaVR team and distinguished Board to expand adoption of its vast capabilities,” said Elias. “I share the company’s commitment to helping people achieve their best health and welcome the opportunity to contribute to its efforts to achieve this important mission.”

Prior to joining Merck, Dr. Elias served as vice president of clinical product development at Aetna, vice president of corporate strategy and business development at Becton Dickinson, and a partner at Essex Woodlands Healthcare Partners, a healthcare-only growth equity firm. Earlier in her career, she was a management consultant at McKinsey, advising pharmaceutical, diagnostic and device companies in R&D, product commercialization and M&A.

Dr. Elias currently serves on the boards of medical device companies Avinger, Inc. and REVA Medical, and she has previously served on the boards of Millennium Pharmacy Systems, BreatheAmerica, Influence Health, and ATS Medical.

Tamara Elias, M.D. holds a Bachelor of Arts in Biology and Anthropology from Yale University and a Doctor of Medicine from The Johns Hopkins School of Medicine. She trained as a general surgeon at Massachusetts General Hospital.

spot_img

DON'T MISS

Dr Jonathan Slotkin Appointed to Peer Well Board of Directors

Alongside the appointment, PeerWell is launching its new clinical practice, PeerWell Health.

Zimmer Biomet Announces New Appointments to Executive Leadership Team

Wilfred van Zuilen Appointed as President of Europe, Middle East and Africa. Nitin Goyal, M.D. Appointed to Newly Created Role of Chief Science, Technology and Innovation Officer.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.